Physiologically based pharmacokinetic rat model for methyl tertiary-butyl ether; comparison of selected dose metrics following various MTBE exposure scenarios used for toxicity and carcinogenicity evaluation

被引:11
作者
Borghoff, Susan J. [1 ]
Parkinson, Horace [2 ]
Leavens, Teresa L. [3 ]
机构
[1] Integrated Lab Syst Inc, Durham, NC 27713 USA
[2] Hamner Inst Hlth Sci, Res Triangle Pk, NC 27709 USA
[3] N Carolina State Univ, Coll Vet Med, Ctr Chem Toxicol Res & Pharmacokinet, Raleigh, NC 27606 USA
关键词
MTBE; TBA; PBPK; RENAL-CELL PROLIFERATION; MALE FISCHER-344 RATS; ALPHA-2U-GLOBULIN NEPHROPATHY; F344; RATS; WATER-INTAKE; ALCOHOL; BIOTRANSFORMATION; DOSIMETRY; MICE;
D O I
10.1016/j.tox.2010.06.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There are a number of cancer and toxicity studies that have been carried out to assess hazard from methyl tertiary-butyl ether (MTBE) exposure via inhalation and oral administration. MTBE has been detected in surface as well as ground water supplies which emphasized the need to assess the risk from exposure via drinking water contamination. This model can now be used to evaluate route-to-route extrapolation issues concerning MTBE exposures but also as a means of comparing potential dose metrics that may provide insight to differences in biological responses observed in rats following different routes of MTBE exposure. Recently an updated rat physiologically based pharmacokinetic (PBPK) model was published that relied on a description of MTBE and its metabolite tertiary-butyl alcohol (TBA) binding to alpha 2u-globulin, a male rat-specific protein. This model was used to predict concentrations of MTBE and TBA in the kidney, a target tissue in the male rat. The objective of this study was to use this model to evaluate the dosimetry of MTBE and TBA in rats following different exposure scenarios, used to evaluate the toxicity and carcinogenicity of MTBE, and compare various dose metrics under these different conditions. Model simulations suggested that although inhalation and drinking water exposures show a similar pattern of MTBE and TBA exposure in the blood and kidney (i.e. concentration-time profiles), the total blood and kidney levels following exposure of MTBE to 7.5 mg/ml MTBE in the drinking water for 90 days is in the same range as administration of an oral dose of 1000 mg/kg MTBE. Evaluation of the dose metrics also supports that a high oral bolus dose (i.e. 1000 mg/kg MTBE) results in a greater percentage of the dose exhaled as MTBE with a lower percent metabolized to TBA as compared to dose of MTBE that is delivered over a longer period of time as in the case of drinking water. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:79 / 91
页数:13
相关论文
共 30 条
[1]   Biotransformation and kinetics of excretion of methyl-tert-butyl ether in rats and humans [J].
Amberg, A ;
Rosner, E ;
Dekant, W .
TOXICOLOGICAL SCIENCES, 1999, 51 (01) :1-8
[2]  
[Anonymous], 1996, GUID CAR US LAB AN
[3]   METHYL-TERTIARY-BUTYL ETHER (MTBE) - A GASOLINE ADDITIVE - CAUSES TESTICULAR AND LYMPHOHAEMATOPOIETIC CANCERS IN RATS [J].
BELPOGGI, F ;
SOFFRITTI, M ;
MALTONI, C .
TOXICOLOGY AND INDUSTRIAL HEALTH, 1995, 11 (02) :119-149
[4]  
BERMUDEZ E, 2009, TOXICOLOGIST, V1481
[5]   Biotransformation of 12C- and 2-13C-labeled methyl tert-butyl ether, ethyl tert-butyl ether, and tert-butyl alcohol in rats:: Identification of metabolites in urine by 13C nuclear magnetic resonance and gas chromatography mass spectrometry [J].
Bernauer, U ;
Amberg, A ;
Scheutzow, D ;
Dekant, W .
CHEMICAL RESEARCH IN TOXICOLOGY, 1998, 11 (06) :651-658
[6]  
Bird MG, 1997, J APPL TOXICOL, V17, pS45, DOI 10.1002/(SICI)1099-1263(199705)17:1+<S45::AID-JAT410>3.3.CO
[7]  
2-B
[8]  
Blancato Jerry N., 2007, J. Environ. Prot. Sci, V1, P29
[9]   Development of a physiologically based pharmacokinetic model for methyl tertiary-butyl ether and tertiary-butanol in male Fischer-344 rats [J].
Borghoff, SJ ;
Murphy, JE ;
Medinsky, MA .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1996, 30 (02) :264-275
[10]   BIOCHEMICAL-MECHANISMS AND PATHOBIOLOGY OF ALPHA-2U-GLOBULIN NEPHROPATHY [J].
BORGHOFF, SJ ;
SHORT, BG ;
SWENBERG, JA .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1990, 30 :349-367